Our goal is to understand how multi-gene clusters are organized and regulated. Specifically, how does the physical organization influence expression of the genes & how is a particular gene within an open cluster chosen for expression? The model evolving from studies of the human beta-globin cluster is that control elements upstream of the genes are essential for locus activation (chromatin opening). These upstream elements also increase the expression of the nearest available genes, with availability chiefly determined by the promoter. This model is supported by the genotype/phenotype correlations observed in patients with deletional beta-thalassemia and hereditary persistence of fetal hemoglobin. We have shown previously that the chicken beta-globin gene, with its 3' enhancer, is expressed in a copy number dependent manner in transgenic mice. The expression level increased approximately 6-fold upon inclusion of the four upstream DNase hypersensitive sites. Each of the four beta- like globins were shown to be under the control of both the upstream hypersensitive sites and the enhancer located between the beta and epsilon genes. To study the effect of the individual upstream hypersensitive sites, we produced lines of mice carrying a single site linked to the beta gene and enhancer. These experiments demonstrated that no single upstream hypersensitive site accounts for the increased beta-globin expression seen in mice containing the complete upstream region. Taken together, our work demonstrates that at least three regions (the beta/epsilon enhancer and at least two upstream sites) plus the promoter are required for proper expression of the individual beta-like globins. Butyrate stimulates the expression of fetal globins in adult cells and is undergoing clinical trials for this purpose. We used transient expression to explore the mechanism of butyrate's actions and found two effects. First, low concentrations of butyrate caused an inhibition of reporter expression. The second effect was stimulation of reporter expression and required higher butyrate concentrations and was promoter-dependent. We postulate that the initial inhibition is due to butyrate-influenced packaging of the transfected DNA into a less transcriptionally active configuration.

Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Yamauchi, T; Kamon, J; Waki, H et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-6
Ebihara, K; Ogawa, Y; Masuzaki, H et al. (2001) Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 50:1440-8
Reitman, M L; Bi, S; Marcus-Samuels, B et al. (2001) Leptin and its role in pregnancy and fetal development--an overview. Biochem Soc Trans 29:68-72
Tansey, J T; Sztalryd, C; Gruia-Gray, J et al. (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 98:6494-9
Reitman, M L; Gavrilova, O (2000) A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes. Int J Obes Relat Metab Disord 24 Suppl 4:S11-4
Draznin, B; Miles, P; Kruszynska, Y et al. (2000) Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia. Endocrinology 141:1310-6
Speckman, R A; Garg, A; Du, F et al. (2000) Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet 66:1192-8
Gavrilova, O; Marcus-Samuels, B; Leon, L R et al. (2000) Leptin and diabetes in lipoatrophic mice. Nature 403:850; discussion 850-1
Chao, L; Marcus-Samuels, B; Mason, M M et al. (2000) Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106:1221-8
Deng, J; St Clair, M; Everett, C et al. (2000) Buprenorphine given after surgery does not alter renal ischemia/reperfusion injury. Comp Med 50:628-32

Showing the most recent 10 out of 21 publications